Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Zivo Bioscience Q2 EPS $(0.43) Misses $(0.41) Estimate, Sales $53.400K Miss $150.000K Estimate

Author: Benzinga Newsdesk | August 14, 2025 05:47pm
Zivo Bioscience (NASDAQ:ZIVO) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.41) by 4.88 percent. This is a 84.53 percent increase over losses of $(2.78) per share from the same period last year. The company reported quarterly sales of $53.400 thousand which missed the analyst consensus estimate of $150.000 thousand by 64.40 percent.

Posted In: ZIVO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist